Skip to main content
. Author manuscript; available in PMC: 2021 Jan 25.
Published in final edited form as: Ann Allergy Asthma Immunol. 2020 May 7;125(3):319–324. doi: 10.1016/j.anai.2020.04.035

Table 2.

Patient-reported outcomes and healthcare use by sleep duration in adults with asthma: Weighted bivariate analysisa

Sleep Duration
Total (n = 1389) ≤ 5 (n = 359) 6–8 (n = 916) ≥ 9 (n = 114) P value
Activity limitation due to wheezing in past yr, n (%)
None 902 (67.9) 210 (60.45) 614 (70.3) 78 (68.6) 0.001
A little 222 (16.7) 56 (17.0) 154 (17.1) 12 (12.1)
Frequent 265 (15.4) 93 (22.6) 148 (12.6) 24 (19.3)
Health-related quality of life
 Days physical health was not good 6.1 (0.4) 8.6 (0.8) 5.0 (0.3) 8.1 (0.3) 0.003
 Days mental health was not good 6.1 (0.4) 9.8 (0.7) 4.8 (0.4) 7.0 (0.9) <0.001
 Inactive days due to health 4.0 (0.3) 6.7 (0.8) 2.8 (0.3) 6.6 (1.1) 0.001
Number of times received healthcare in past yr 2.6 (0.0) 2.8 (0.1) 2.5 (0.0) 3.0 (0.2) 0.58
Number of times received healthcare for wheezing in past yr 0.7 (0.1) 0.7 (0.1) 0.6 (0.1) 0.9 (0.2) 0.83
a

Data is presented as mean (standard deviation), unless otherwise indicated.